Cargando…
Biocompatible AIEgen/p-glycoprotein siRNA@reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in ovarian cancer
Nanoparticle drug delivery system (NDDS) is quite different from the widely studied traditional chemotherapy which suffers from drug resistance and side effect. NDDS offers the straightforward solution to the chemotherapy problem and provides an opportunity to monitor the drug delivery process in re...
Autores principales: | Wu, Jun, Wang, Quan, Dong, Xiaoqi, Xu, Min, Yang, Juliang, Yi, Xiaoqing, Chen, Biao, Dong, Xiyuan, Wang, Ying, Lou, Xiaoding, Xia, Fan, Wang, Shixuan, Dai, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914360/ https://www.ncbi.nlm.nih.gov/pubmed/33664857 http://dx.doi.org/10.7150/thno.53828 |
Ejemplares similares
-
Cooperation therapy between anti-growth by photodynamic-AIEgens and anti-metastasis by small molecule inhibitors in ovarian cancer
por: Dai, Jun, et al.
Publicado: (2020) -
Exploration of biocompatible AIEgens from natural resources
por: Gu, Yuan, et al.
Publicado: (2018) -
Prodrug Strategies for Paclitaxel
por: Meng, Ziyuan, et al.
Publicado: (2016) -
Integration of Dual Targeting and Dual Therapeutic Modules Endows Self-Assembled Nanoparticles with Anti-Tumor Growth and Metastasis Functions
por: Chen, Biao, et al.
Publicado: (2021) -
Red blood cell membrane-camouflaged nanoparticles loaded with AIEgen and Poly(I : C) for enhanced tumoral photodynamic-immunotherapy
por: Dai, Jun, et al.
Publicado: (2021)